Cann Stock Ratings and Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cann. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cann.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
6/11/2018CannLowers TargetTESARO (TSRO)Outperform$122.00 -> $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2018CannReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/8/2018CannReiteratesAmgen (AMGN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/4/2018CannReiteratesTESARO (TSRO)Buy $122.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/30/2018CannReiteratesExelixis (EXEL)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018CannReiteratesExelixis (EXEL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/17/2018CannReiteratesSeattle Genetics (SGEN)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
5/10/2018CannReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018CannReiteratesAcceleron Pharma (XLRN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
5/1/2018CannReiteratesIntellia Therapeutics (NTLA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018CannReiteratesKura Oncology (KURA)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
4/17/2018CannReiteratesAgios Pharmaceuticals (AGIO)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/8/2018CannReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2018CannReiteratesKura Oncology (KURA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
3/23/2018CannInitiatesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
3/21/2018CannReiteratesMEI Pharma (MEIP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018CannReiteratesExelixis (EXEL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/20/2018CannReiteratesSeattle Genetics (SGEN)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
3/19/2018CannReiterates1-800-Flowers.Com (FLWS)SellMediumView Rating Details  Share on Twitter  Share on StockTwits
3/8/2018CannReiteratesExelixis (EXEL)Buy $40.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/7/2018CannReiteratesCTI BioPharma (CTIC)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/2/2018CannReiteratesInsys Therapeutics (INSY)AverageHighView Rating Details  Share on Twitter  Share on StockTwits
3/1/2018CannReiteratesLoxo Oncology (LOXO)Buy $122.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018CannReiteratesTESARO (TSRO)Buy$199.00 -> $122.00MediumView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018CannReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/27/2018CannUpgradesExelixis (EXEL)Market Perform -> Outperform $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/23/2018CannInitiatesCTI BioPharma (CTIC)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
2/21/2018CannInitiatesLoxo Oncology (LOXO)Outperform $132.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/16/2018CannReiteratesEditas Medicine (EDIT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
2/16/2018CannReiteratesKura Oncology (KURA)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
2/15/2018CannReiteratesCelgene (CELG)Buy $163.00LowView Rating Details  Share on Twitter  Share on StockTwits
2/8/2018CannReiteratesMEI Pharma (MEIP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
2/2/2018CannReiteratesMiragen Therapeutics (MGEN)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/26/2018CannReiteratesVerastem (VSTM)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/12/2018CannInitiatesMiragen Therapeutics (MGEN)Outperform $13.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018CannReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
1/8/2018CannReiteratesMirati Therapeutics (MRTX)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2018CannReiteratesExelixis (EXEL)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
12/21/2017CannReiteratesMEI Pharma (MEIP)Buy $6.50MediumView Rating Details  Share on Twitter  Share on StockTwits
12/12/2017CannReiteratesEpizyme (EPZM)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017CannReiteratesKura Oncology (KURA)Buy $17.50MediumView Rating Details  Share on Twitter  Share on StockTwits
12/11/2017CannReiteratesMEI Pharma (MEIP)Buy $6.50HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2017CannReiteratesVerastem (VSTM)Buy$6.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2017CannReiteratesCrispr Therapeutics (CRSP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017CannReiteratesAgios Pharmaceuticals (AGIO)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
12/5/2017CannDowngradesTesla (TSLA)Hold -> SellLowView Rating Details  Share on Twitter  Share on StockTwits
11/30/2017CannReiteratesAmgen (AMGN)Buy $205.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/22/2017CannReiteratesCelgene (CELG)Buy $166.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2017CannReiteratesCrispr Therapeutics (CRSP)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017CannInitiatesSeattle Genetics (SGEN)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2017CannReiteratesKura Oncology (KURA)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017CannReiteratesTESARO (TSRO)Buy $199.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017CannReiteratesEditas Medicine (EDIT)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2017CannReiteratesVerastem (VSTM)Buy $6.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/2/2017CannReiteratesEpizyme (EPZM)Buy $26.00N/AView Rating Details  Share on Twitter  Share on StockTwits
10/26/2017CannReiteratesCelgene (CELG)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
10/16/2017CannReiteratesExelixis (EXEL)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/6/2017CannReiteratesAmgen (AMGN)Buy $203.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/19/2017CannReiteratesEpizyme (EPZM)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/19/2017CannInitiatesMirati Therapeutics (MRTX)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
9/11/2017CannReiteratesClovis Oncology (CLVS)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
9/8/2017CannReiteratesTESARO (TSRO)Buy $199.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/8/2017CannReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
9/5/2017CannReiteratesAcceleron Pharma (XLRN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
8/29/2017CannReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
8/28/2017CannReiteratesAmgen (AMGN)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
8/21/2017CannReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/16/2017CannReiteratesVerastem (VSTM)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
8/10/2017CannReiteratesEditas Medicine (EDIT)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
8/8/2017CannReiteratesCytomX Therapeutics (CTMX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
8/1/2017CannReiteratesCelgene (CELG)Buy $175.00LowView Rating Details  Share on Twitter  Share on StockTwits
8/1/2017CannReiteratesIntellia Therapeutics (NTLA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
7/31/2017CannReiteratesClovis Oncology (CLVS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
7/26/2017CannReiteratesAmgen (AMGN)Buy$189.00 -> $203.00LowView Rating Details  Share on Twitter  Share on StockTwits
7/25/2017CannReiteratesVerastem (VSTM)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
7/20/2017CannReiteratesExelixis (EXEL)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017CannInitiatesEditas Medicine (EDIT)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017CannInitiatesCrispr Therapeutics (CRSP)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
7/17/2017CannReiteratesIntellia Therapeutics (NTLA)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
7/14/2017CannInitiatesHimax (HIMX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/26/2017CannReiteratesMEI Pharma (MEIP)Buy $6.50HighView Rating Details  Share on Twitter  Share on StockTwits
6/26/2017CannReiteratesVerastem (VSTM)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/23/2017CannReiteratesAcceleron Pharma (XLRN)Neutral -> HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/22/2017CannInitiatesClovis Oncology (CLVS)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
6/21/2017CannReiteratesEpizyme (EPZM)Buy $26.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/19/2017CannReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
6/13/2017CannReiteratesAcceleron Pharma (XLRN)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
6/11/2017CannReiteratesAgios Pharmaceuticals (AGIO)Buy $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
6/7/2017CannReiteratesCelgene (CELG)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
6/5/2017CannReiteratesMEI Pharma (MEIP)Buy $6.50MediumView Rating Details  Share on Twitter  Share on StockTwits
6/5/2017CannReiteratesTESARO (TSRO)Buy $199.00HighView Rating Details  Share on Twitter  Share on StockTwits
6/1/2017CannReiteratesAcceleron Pharma (XLRN)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
5/24/2017CannReiteratesTESARO (TSRO)OutperformMediumView Rating Details  Share on Twitter  Share on StockTwits
5/24/2017CannReiteratesMEI Pharma (MEIP)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
5/15/2017CannReiteratesKura Oncology (KURA)Buy $16.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/11/2017CannReiteratesVerastem (VSTM)Buy $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
5/3/2017CannUpgradesBoyd Gaming (BYD)Buy$20.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/27/2017CannReiteratesSeattle Genetics (SGEN)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/27/2017CannReiteratesCelgene (CELG)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
4/25/2017CannReiteratesEpizyme (EPZM)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/19/2017CannReiteratesExelixis (EXEL)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
4/19/2017CannReiteratesAgios Pharmaceuticals (AGIO)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2017CannReiteratesVerastem (VSTM)Outperform $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/12/2017CannReiteratesEpizyme (EPZM)Outperform $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/5/2017CannReiteratesKura Oncology (KURA)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
4/4/2017CannReiteratesCelgene (CELG)Buy $148.00LowView Rating Details  Share on Twitter  Share on StockTwits
3/30/2017CannReiteratesCytomX Therapeutics (CTMX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017CannInitiatesSeattle Genetics (SGEN)Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017CannInitiatesExelixis (EXEL)Market Perform -> PositiveHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017CannReiteratesKura Oncology (KURA)OutperformHighView Rating Details  Share on Twitter  Share on StockTwits
3/15/2017CannReiteratesAmgen (AMGN)Outperform -> Positive $189.00MediumView Rating Details  Share on Twitter  Share on StockTwits
3/6/2017CannReiteratesKura Oncology (KURA)Outperform $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/2/2017CannReiteratesCelgene (CELG)Positive -> Outperform $148.00N/AView Rating Details  Share on Twitter  Share on StockTwits
3/1/2017CannReiteratesAcceleron Pharma (XLRN)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
2/28/2017CannReiteratesAmgen (AMGN)Positive -> Outperform $189.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2017CannReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/24/2017CannReiteratesCelgene (CELG)Outperform $148.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/22/2017CannReiteratesAmgen (AMGN)OutperformN/AView Rating Details  Share on Twitter  Share on StockTwits
2/21/2017CannReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/8/2017CannRaises TargetKura Oncology (KURA)Outperform $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
2/3/2017CannReiteratesAmgen (AMGN)Buy $175.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/26/2017CannReiteratesCelgene (CELG)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
1/24/2017CannReiteratesSynaptics (SYNA)Underperform $45.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/17/2017CannUpgradesAgios Pharmaceuticals (AGIO)Market Perform -> Outperform $75.00N/AView Rating Details  Share on Twitter  Share on StockTwits
1/3/2017CannDowngradesHerman Miller (MLHR)Market Perform -> UnderperformN/AView Rating Details  Share on Twitter  Share on StockTwits
1/3/2017CannReiteratesCytomX Therapeutics (CTMX)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
12/20/2016CannReiteratesCelgene (CELG)Buy $141.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/16/2016CannReiteratesAgios Pharmaceuticals (AGIO)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016CannInitiatesAcceleron Pharma (XLRN)Outperform$367.30 -> $44.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016CannInitiatesAmgen (AMGN)Buy $166.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/12/2016CannReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016CannReiteratesSyros Pharmaceuticals (SYRS)Buy $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016CannReiteratesCelgene (CELG)Buy $141.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2016CannReiteratesCytomX Therapeutics (CTMX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016CannInitiatesAgios Pharmaceuticals (AGIO)Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016CannInitiatesSyros Pharmaceuticals (SYRS)Outperform $28.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2016CannInitiatesCelgene (CELG)Outperform $141.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/8/2016CannDowngradesPier 1 Imports (PIR)Strong-Buy -> Market PerformN/AView Rating Details  Share on Twitter  Share on StockTwits
3/11/2015CannUpgradesTullow Oil (TUWLF)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2015CannUpgradesRIGHTMOVE PLC/ADR (RTMVY)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
2/27/2015CannUpgradesStandard Chartered (SCBFF)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
12/5/2014CannInitiatesWetherspoons (JDWPY)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
10/3/2014CannLowers TargetCree (CREE) $41.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/15/2014CannInitiatesWhiting Petroleum (WLL)Buy $432.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/15/2014CannInitiatesContinental Resources (CLR)Buy $92.00N/AView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Saturday at 01:34 PM ET.

MarketBeat Community Rating for Cann

Community Ranking:  0.0 out of 5 (star star star star)
Outperform Votes:  0 (Vote Outperform)
Underperform Votes:  8,812 (Vote Underperform)
Total Votes:  8,812
MarketBeat's community ratings are surveys of what our community members think about Cann and other research firms. Vote "Outperform" if you believe Cann's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cann's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.